ArticleACS omega2025
Size Effect of Mesoporous Bioactive Glass on Macrophage Polarization.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Macrophages, one of the key immune cells, are closely associated with various diseases and play critical roles in tissue regeneration via proper polarization. Mesoporous bioactive glass (MBG) has been widely used in bone tissue regeneration; thus, it is charming and beneficial to understand the interactions between MBG and the immune system. Herein, MBG particles with sizes of about 75 nm (MBG-1), 200 nm (MBG-2), and 500 nm (MBG-5) were prepared, and their size effects on macrophage polarization were investigated. The results demonstrated that small MBG particles (75 nm) promoted macrophage polarization toward the M2 phenotype while inhibiting M1 polarization at an early stage (3 days). Meanwhile, medium-sized MBG particles (200 nm) induce a mild inflammatory response in the early stage and promote a high proportion of anti-inflammatory M2 macrophages in the late stage. In contrast, large-sized MBG particles (500 nm) trigger a strong multidirectional activation of macrophages during the early stage, accompanied by a marked upregulation in the expression of both M1 and M2 phenotypic markers. This work preliminarily investigates the relationship between the particle size of MBG and polarization of macrophages, providing insights for the design and further applications of MBG-based biomaterials.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.